Impact of Predilatation Prior to Transcatheter Aortic Valve Implantation with the Self-Expanding Acurate neo Device (From the Multicenter NEOPRO Registry)

Safety and feasibility of transfemoral Acurate neo implantation without systematic predilatation are not fully investigated. Our aim was to evaluate the use and impact of pre-implantation balloon aortic valvuloplasty (pre-BAV) before transcatheter aortic valve implantation (TAVI) with Acurate neo. The NEOPRO Registry retrospectively included 1,263 patients who underwent transfemoral TAVI with Acurate neo at 18 centers between January 2012 and March 2018. Information on pre-BAV was available for 1,262 patients (99.9%).

Source: The American Journal of Cardiology - February 7, 2020 Category: Cardiology Authors: Matteo Pagnesi, Won-Keun Kim, Lenard Conradi, Marco Barbanti, Giulio G. Stefanini, Joachim Schofer, David Hildick-Smith, Thomas Pilgrim, Alexandre Abizaid, David Zweiker, Luca Testa, Maurizio Taramasso, Alexander Wolf, John G. Webb, Alexander Sedaghat, Ja Source Type: research